Medical Affairs Strategic Summit West (MASS West) 2022: Full Schedule

1:00pm PDT

Medical Affairs Strategy Track Chair Opening Remarks

Speakers

Blake Morrison, PharmD

Vice President, Global Medical Affairs, Turning Point Therapeutics

Blake brings over 30 years of clinical practice and industry experience with a therapeutic area emphasis on hematology/oncology. Blake’s functional area of expertise is medical affairs and includes extensive experience in building and leading oncology-focused medical affairs teams... Read More →

Wednesday September 21, 2022 1:00pm - 1:15pm PDT

Medical Affairs Strategy

1:15pm PDT

Establish the Value of Medical Affairs in Small Pharma to Ensure Proactive Collaboration and Alignment with Partners   

Speakers

Mirta Grifman

Vice President, Medical Affairs, Biosplice, Inc.

Wednesday September 21, 2022 1:15pm - 1:45pm PDT

Medical Affairs Strategy

1:45pm PDT

Influence and Impact: Data Science for Effective HCP Engagement Med Affairs Strategy

How Medical Affairs/MSLs can use AI, technology and data insights to find and prioritize KOLs
How to use data to prepare for engagements and keep KOLs up to date on pharma developments
How to use data to “get smart” on a KOLs history, digital presence and recent publications

Speakers

Ian Bailey

Senior Account Executive, H1

Ian is a Senior Global Account Executive at H1 with more than 9 years of experience in SaaS technology, enterprise process transformation, and SaaS software evaluation. A problem-solver at heart, he currently leads business growth for H1 where he partners with the Medical Affairs... Read More →

Wednesday September 21, 2022 1:45pm - 2:15pm PDT

Medical Affairs Strategy

2:15pm PDT

PANEL: Finding the Right Metrics to Accurately Exhibit the True Value of Medical Affairs Engagement   

Moderators

Richard Swank

Head, Global and US Field Medical, Amgen

Rich heads Global Field Medical at Amgen, encompassing medical science liaisons across all therapeutic areas as well as Global Field Medical Excellence. He has 20+ years of Biotech and Pharma experience ranging from discovery research to product launches and has spent most of his... Read More →

Speakers

Avery Ince

Vice President, Medical Affairs - Cardiovascular & Metabolism Franchise, Janssen

Peter Gin-Fu Chen, PhD

VP, Head of US Medical Rare Blood Disorders, Sanofi

Peter brings over a decade of industry experience largely focused on rare disease. He has held roles or increasing responsibility as a MSL, Medical Director, Clinical Development, and Medical Affairs leadership. Peter currently serves as Head of US Medical Affairs, Rare Blood, at... Read More →

Sarica Klein

National Director Field Medical Affairs, Hematology, Sobi North America

Sarica Klein earned her PharmD from the University of Southern California in 2006. She has worked in the pharmaceutical industry ever since gaining experiences in home office roles, medical science liaison positions and field management. Sarica currently works at Sobi North America... Read More →

Wednesday September 21, 2022 2:15pm - 3:00pm PDT

Medical Affairs Strategy

4:15pm PDT

Measuring and Optimizing Medical Affairs Impact with Share of Scientific Voice™

Pharmaspectra leverages the world's largest scientific data lake to deliver the most accurate KOL identifications, profiling and measurement of Medical affairs impact through Share of Scientific Voice™. Over the last 18 years Pharmaspectra has partnered with the Medical Affairs, R&D and Commercial teams across 18 of the top 25 pharma companies to improve their strategic planning, decision-making and impact.
In August 2022, Pharmaspectra became a part of IQVIA, a leading global provider of information, innovative technology solutions and contract research services, further strengthening and widening the data and capabilities available to our clients.

Speakers

Matt Rogers

Director of Business Development, Pharmaspectra, an IQVIA Business 

Matt joined Pharmaspectra 2.5 years ago as National Director of Business Development, and has spent the last 6 years in the pharmaceutical and healthcare industry, most recently withThomson Reuters and Stryker Spine.

Allyson Metcalf

Director, Business Development, Pharmaspectra, an IQVIA Business

Allyson joined Pharmaspectra over a year ago as the Director of Business Development covering the West Coast, USA. She has over two decades of experience working in the pharmaceutical industry, including 15 years with Merck and Co.

Wednesday September 21, 2022 4:15pm - 4:45pm PDT

Medical Affairs Strategy

4:45pm PDT

Medical Affairs Strategy Interactive Activity

A collaborative group activity that will allow attendees to work together to answer a set of questions highlighting major aspects of medical affairs strategy development.
Questions to be shared on the conference date

Speakers

Blake Morrison, PharmD

Vice President, Global Medical Affairs, Turning Point Therapeutics

Wednesday September 21, 2022 4:45pm - 5:30pm PDT

Medical Affairs Strategy

5:30pm PDT

Medical Affairs Strategy Track Chair Closing Remarks

Speakers

Blake Morrison, PharmD

Vice President, Global Medical Affairs, Turning Point Therapeutics

Wednesday September 21, 2022 5:30pm - 5:30pm PDT

Medical Affairs Strategy

1:00pm PDT

Medical Affairs Strategy Track Chair Opening Remarks

Speakers

Blake Morrison, PharmD

Vice President, Global Medical Affairs, Turning Point Therapeutics

Thursday September 22, 2022 1:00pm - 1:15pm PDT

Medical Affairs Strategy

1:15pm PDT

The Evolution of Medical Affairs: Playing a Leading Role in the Product Lifecycle Within the Healthcare Ecosystem

Be a key strategic team player with clinical research, development, commercial and compliance teams
Leading innovation through data generation & medical information/communication \

Speakers

Blake Morrison, PharmD

Vice President, Global Medical Affairs, Turning Point Therapeutics

Thursday September 22, 2022 1:15pm - 1:45pm PDT

Medical Affairs Strategy

1:45pm PDT

Publication Strategy: Driving Data to Reach Across Channels and Audiences

Speakers

Eric Jen

Publications Strategy and Medical Education, Neurocrine

Thursday September 22, 2022 1:45pm - 2:15pm PDT

Medical Affairs Strategy

2:15pm PDT

PANEL: Find the Best Study Option for New Data Procurement

Moderators

Oscar Segurado

Chief Medical Officer, ASC Therapeuti

Oscar Segurado, MD, PhD, is the Chief Medical Officer for ASC Therapeutics, responsible for translational science into clinical development and global regulatory filings.ASC Therapeutics is a fast-growing biotechnology company focused on developing curative gene- and cell-based therapies... Read More →

Speakers

Sarah Kennedy, PhD

Executive Director, Medical Affairs, Biosplice Therapeutics

Sarah Kennedy, PhD, is the executive director of medical affairs at Biosplice Therapeutics. Her current role encompasses the breadth of medical affairs, ranging from field strategy and publication planning to clinical and commercial support.

Hao Zhang

Executive Director, Statistical Science - Head of Post-Approval Statistical Science, BioMarin Pharmaceutical

Hao Zhang, PhD, is an experienced and passionate data and evidence generation professional with 28+ years' experience in bio-pharmaceutical industry. Hao earned his PhD in Statistics from the Wharton School of the University of Pennsylvania and has served in very diversified roles... Read More →

James Mun, PhD

Director of Scientific and Medical Communications, Tarsus Pharmaceuticals, Inc.

Thursday September 22, 2022 2:15pm - 3:00pm PDT

Medical Affairs Strategy

3:00pm PDT

Medical Affairs Strategy Track Chair Closing Remarks

Thursday September 22, 2022 3:00pm - 3:15pm PDT

Medical Affairs Strategy